MDCX (Medicus Pharma Ltd. Common Stock) Stock Analysis - Analyst Ratings

Medicus Pharma Ltd. Common Stock (MDCX) is a publicly traded Healthcare sector company. As of May 21, 2026, MDCX trades at $0.29 with a market cap of $16.06M and a P/E ratio of -0.11. MDCX moved +5.00% today. Year to date, MDCX is -81.88%; over the trailing twelve months it is -96.19%. Its 52-week range spans $0.25 to $8.94. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces MDCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MDCX?

2 analysts cover MDCX: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.50.

MDCX Key Metrics

Key financial metrics for MDCX
MetricValue
Price$0.29
Market Cap$16.06M
P/E Ratio-0.11
EPS$-2.69
Dividend Yield0.00%
52-Week High$8.94
52-Week Low$0.25
Volume11.90K
Avg Volume0
Revenue (TTM)$-221.25K
Net Income$-39.38M
Gross Margin0.00%

MDCX Analyst Consensus

2 analysts cover MDCX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.

Latest MDCX News

Recent MDCX Insider Trades

  • VELOCITY FUND PARTNERS, LP sold 75.00K (~$578.94K) on May 20, 2025.

Common questions about MDCX

What do analysts rate MDCX?
2 analysts cover MDCX: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.50.
Does Rallies show MDCX price targets?
Yes. Rallies tracks MDCX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MDCX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MDCX. It does not provide personalized investment advice.
MDCX

MDCX